Concepedia

Michael D. Tarantino

MD

63

Publications

3.9K

Citations

32

H-Index

1991

Active since

Affiliations

Bleeding & Clotting Disorders Institute(Current)

Illinois College

Amgen (United States)

Indiana Hemophilia and Thrombosis Center

Cornell University

Michael D. Tarantino is an author at Bleeding & Clotting Disorders Institute specializing in medicine, hematology, and thrombosis.

ORCID

Top concepts

Publications per year

1991–2025

63

Publications

63

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 851 citations

, , +9

Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination

Eun‐Ju Lee, Douglas B. Cines, Terry Gernsheimer et al. · American Journal of Hematology · 2021 · 383 citations · Full text

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

Michael D. Tarantino, James B. Bussel, Victor S. Blanchette et al. · The Lancet · 2016 · 147 citations

, , +11

The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings

Julian Lin, William C. Hanigan, Michael D. Tarantino et al. · Journal of neurosurgery · 2003 · 141 citations

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin‐free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A<sup>1</sup>

Michael D. Tarantino, Peter W. Collins, C. R. M. Hay et al. · Haemophilia · 2004 · 138 citations

Rows per page

1–5 of 63